|Market Size in 2022||Market Forecast in 2030||CAGR (in %)||Base Year|
|USD 9.1 Billion||USD 13.2 Billion||7.75%||2022|
Automated Cell Counters Market
The global automated cell counters market size was evaluated at $9.1 billion in 2022 and is slated to hit $13.2 billion by the end of 2030 with a CAGR of nearly 7.75% between 2023 and 2030.
Automated cell counters are electronic devices that count the cells in plants, animals, human beings, viruses, and bacteria along with the cells of other origins. Furthermore, the cell counting process commences with the loading of a section into an automated cell counter, which is then passed over a narrow tube. Moreover, these products find a slew of applications in lab tests for counting cells.
Rise in the incidences of chronic diseases globally will steer the global market expansion by 2030
A prominent surge in the cases of diseases such as cancer, HIV, diphtheria, measles, and other kinds of blood disorders will drive the global automated cell counters market trends. A surge in the need for counting cells for diagnosis and treatment of chronic illness will further embellish the expansion of the global market. As per the report of WHO published in November 2021, nearly 38 million got infected with HIV by 2020. Moreover, in 2020, about 7, 00,000 individuals died due to HIV. Furthermore, a rise in scientific and technological breakthroughs will favorably leverage the expansion of the market across the globe. Supportive government policies and huge fund allocations in research activities pertaining to the
development of new automated cell counters will spearhead the market space in the coming years. New product launches have favorably impacted the expansion of each market and are likely to do so even in the foreseeable future. For instance, in August 2022, DeNovix Inc., a key manufacturer of CellDrop Automated Cell Counter, launched two nuclei counting applications of varied isolated nuclei & intact cells. Additionally, in April 2021, CytoSMART Technologies, a Holland-based firm manufacturing smart devices, launched a fluorescence cell counter referred to as CytoSMART Exact FL, an automated and dual fluorescence cell counter that can provide unrivaled performance and extended view of the field. Such strategic initiatives will impel the scope of the growth of the global market.
High product costs can impede global industry expansion over the next eight years
Huge costs and lack of availability of skilled professionals can hinder the growth of the global automated cell counters industry. Furthermore, poor healthcare facilities in emerging economies are anticipated to halt the expansion of the global industry.
Large-scale consumption of alcoholic beverages will open new growth avenues for the global market
Increase in intake of alcohol and cigar smoking and an unhealthy & haphazard lifestyle along with changing food habits has paved the way for the mammoth growth of the automated cell counters market across the globe.
Stringent government regulations will restrict global industry expansion over the forecast period
Strict government laws mandating approval of using the product as well as licensing of the product can pose a big threat to the expansion of the global automated cell counters industry.
The global automated cell counters market is sectored into product type, application, and region.
In terms of product type, the global automated cell counters market is segregated into fluorescence image-based cell counter, coulter counter, and flow cytometers segments. Furthermore, the fluorescence image-based cell counter segment, which gathered nearly a fourth-fifth of the global market revenue share in 2022, is projected to register the fastest CAGR in the next couple of years. The growth of the segment in the forecasting timespan can be owing to an increase in the number of individuals affected due to urinary tract infections, diabetes, and kidney disorders.
Based on the application, the global automated cell counters industry is sectored into cell lines, blood cells, and microbial segments. Furthermore, the blood cells segment, which garnered a huge chunk of the global industry share in 2022, is forecast to dominate the global industry over the analysis timespan. The segmental expansion over the assessment timespan can be subject to a rise in blood cell diseases such as thalassemia and cancer.
|Report Attributes||Report Details|
|Report Name||Automated Cell Counters Market|
|Market Size in 2022||USD 9.1 Billion|
|Market Forecast in 2030||USD 13.2 Billion|
|Growth Rate||CAGR of 7.75%|
|Number of Pages||220|
|Key Companies Covered||Thermo Fischer Scientific; Abbott Laboratories; Countstar Inc.; Bio-Rad Laboratories Inc.; Agilent Technologies Inc.; Beckman Coulter Inc. (Danaher); F. Hoffmann-La Roche Ltd; Chemometec A/S; ALIGNEDGENETICS; Nanoentek; Olympus Corporation; MERCK KGaA; Sysmex Corporation; Nexcelom Bioscience LLC., and others.|
|Segments Covered||By Application, By Product Type, and By Region|
|Regions Covered||North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)|
|Historical Year||2017 to 2021|
|Forecast Year||2023 - 2030|
|Customization Scope||Avail customized purchase options to meet your exact research needs. Request For Customization|
Asia-Pacific is set to retain dominant position in the global automated cell counters market over 2023-2030
Asia-Pacific, which contributed about two-fifths of the global automated cell counters market revenue in 2022, will be a leading region over the projected timeframe. Furthermore, the regional market growth can be subject to a rise in the presence of giant firms in the countries. Apart from this, the huge demand for toxicology testing equipment and personalized medicine in countries such as Japan and China will proliferate the regional market size. Additionally, rise in the chronic disorders in the emerging economies of Asia will further steer the regional market trends.
North American automated cell counters industry is set to register the fastest CAGR in the ensuing years owing to the rise in the manufacture of medical devices as well as its use in hospitals and clinics in countries such as Canada and the U.S. In addition to this, breakthroughs in the healthcare sector will further promulgate the scope of growth of the industry in the region. Supportive government schemes pertaining to the use of medical devices along with approvals from healthcare authorities such as the U.S. FDA over medical device applications in the healthcare sector will prompt regional industry growth.
The global automated cell counters market profiles key players such as:
By Product Type
Automated cell counters are electronic devices that count the cells in plants, animals, human beings, viruses, and bacteria along with the cells of other origins.
The global automated cell counters market growth can be owing to a surge in the need for counting cells for diagnosis and treatment of chronic illness.
According to a study, the global automated cell counters industry size was $9.1 billion in 2022 and is projected to reach $13.2 billion by the end of 2030.
The global automated cell counters market is anticipated to record a CAGR of nearly 7.75% from 2023 to 2030.
The North American automated cell counters industry is set to register the highest CAGR over the forecasting timeline owing to the rise in the manufacture of medical devices as well as its use in hospitals and clinics in countries such as Canada and the U.S. In addition to this, breakthroughs in the healthcare sector will further promulgate the scope of growth of the industry in the region.
The global automated cell counters market is led by players such as Thermo Fischer Scientific, Abbott Laboratories, Countstar, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Beckman Coulter, Inc. (Danaher), F. Hoffmann-La Roche Ltd, Chemometec A/S, ALIGNEDGENETICS, Nanoentek, Olympus Corporation, MERCK KGaA, Sysmex Corporation, and Nexcelom Bioscience LLC.
The automated cell counters market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTEL analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five force analysis, and value chain analysis.